INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTI- PEROXIDASA TIROIDEA (ANTI- TPO)
Mexico·Clase I·III. Agentes de diagnóstico·INSUMOS PARA LA
SALUD, S.A. DE C.V.·Registered November 07, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- MAGLUMI® ANTI-PEROXIDASA TIROIDEA (CLIA)
- Trade Name (English)
- MAGLUMI® ANTI-PEROXIDASA TIROIDEA (CLIA)
- Analysis ID
- 1290R2022 SSA
- Registration Date
- November 07, 2022
- Name (Spanish)
- INSUMOS PARA LA SALUD, S.A. DE C.V.
- Name (English)
- INSUMOS PARA LA SALUD, S.A. DE C.V.
Access comprehensive regulatory information for INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTI- PEROXIDASA TIROIDEA (ANTI- TPO) (INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTI- PEROXIDASA TIROIDEA (ANTI- TPO)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1290R2022 SSA and manufactured by INSUMOS PARA LA SALUD, S.A. DE C.V.. The device was registered on November 07, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.